Danske Bank’s Incannex Healthcare IXHL Stock Holding History

Danske Bank’s Portfolio IXHL Stock Details IXHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$15	–	1189
2026 Q1	$15	Buy	+5	New	+$36	﹤0.01%	1079

Other funds holding IXHL

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Danske Bank's IXHL Position: Q2 2026 in Review

Danske Bank sold out of Incannex Healthcare (IXHL) in Q2 2026, closing a stake of 5 shares — an estimated $15 sold.

Danske Bank first reported a position in IXHL in Q1 2026 and held it in 1 quarter. The position peaked at $15 in Q1 2026. 15 funds tracked by Wall St. Rank hold IXHL as of Q2 2026.

Danske Bank reported no remaining Incannex Healthcare position as of Q2 2026 after selling out during the quarter.
Danske Bank sold 5 Incannex Healthcare shares in Q2 2026, an estimated $15.
Danske Bank first reported a position in Incannex Healthcare in Q1 2026 and held it in 1 quarter.
Danske Bank's Incannex Healthcare position peaked at $15 in Q1 2026.
15 funds tracked by Wall St. Rank held Incannex Healthcare as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.